$2.29T
Total marketcap
$390.66B
Total volume
BTC 55.58%     ETH 9.33%
Dominance

Biotron BITRF Stock

$0.00   0.000000%
Add to favorites
Market Cap
$2.97M
LOW - HIGH [24H]
$0.00 - $0.00
VOLUME [24H]
$100.00K
P/E Ratio
0
Earnings per share
$0.00
ISIN
AU000000BIT4

Biotron Price Chart

Sorry, that's all we've gotfor now...

Biotron BITRF Financial and Trading Overview

Biotron stock price 0.0011 USD
Previous Close 0.0011 USD
Open 0.005 USD
Bid 0.0011 USD x 3000000
Ask 0.0041 USD x 2000000
Day's Range 0.005 - 0.005 USD
52 Week Range 0.0011 - 0.1 USD
Volume 100K USD
Avg. Volume 4.8K USD
Market Cap 2.97M USD
Beta (5Y Monthly) -0.554
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

BITRF Valuation Measures

Enterprise Value 1.01M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) -3424.023
Price/Book (mrq) 1.5321188
Enterprise Value/Revenue -1160.507
Enterprise Value/EBITDA -0.512

Trading Information

Biotron Stock Price History

Beta (5Y Monthly) -0.554
52-Week Change -88.42%
S&P500 52-Week Change 27.29%
52 Week High 0.1 USD
52 Week Low 0.0011 USD
50-Day Moving Average 0.02 USD
200-Day Moving Average 0.01 USD

BITRF Share Statistics

Avg. Volume (3 month) 4.8K USD
Avg. Daily Volume (10-Days) 170 USD
Shares Outstanding 2.7B
Float 1.74B
Short Ratio N/A
% Held by Insiders 27.48%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2025
Most Recent Quarter (mrq) December 31, 2025
Next Fiscal Year End June 30, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) 226598.14%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -50.98%
Return on Equity (ttm) -122.61%

Income Statement

Revenue (ttm) -868 USD
Revenue Per Share (ttm) 0 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) -868 USD
EBITDA -1968584 USD
Net Income Avi to Common (ttm) -1936170 USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.64M USD
Total Cash Per Share (mrq) 0.001 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 1.469
Book Value Per Share (mrq) 0.00071796

Cash Flow Statement

Operating Cash Flow (ttm) -1923688 USD
Levered Free Cash Flow (ttm) -587568 USD

Profile of Biotron

Country United States
State NSW
City Sydney
Address 66 Hunter Street
ZIP 2000
Phone 61 2 9300 3344
Website https://www.biotron.com.au
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225 for the treatment of SARS-CoV-2, HIV-1, hepatitis C virus, hepatitis B virus (HBV), influenza, and dengue virus infections. The company was incorporated in 1999 and is based in Sydney, Australia.

Q&A For Biotron Stock

What is a current BITRF stock price?

Biotron BITRF stock price today per share is 0.0011 USD.

How to purchase Biotron stock?

You can buy BITRF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Biotron?

The stock symbol or ticker of Biotron is BITRF.

Which industry does the Biotron company belong to?

The Biotron industry is Biotechnology.

How many shares does Biotron have in circulation?

The max supply of Biotron shares is 2.7B.

What is Biotron Price to Earnings Ratio (PE Ratio)?

Biotron PE Ratio is now.

What was Biotron earnings per share over the trailing 12 months (TTM)?

Biotron EPS is 0 USD over the trailing 12 months.

Which sector does the Biotron company belong to?

The Biotron sector is Healthcare.

Select currency